본문 바로가기
KERD
논문KCI 등재

Advanced Test of Attention in Children with Attention-Deficit/Hyperactivity Disorder in Japan for Evaluation of Methylphenidate and Atomoxetine Effects

0

조회

0

다운로드

3

인용

0

참고문헌

키워드

초록

Objective: This study was conducted to validate the Advanced Test of Attention (ATA) of the visual attention version of Japanese children with attention deficit/hyperactivity disorder (ADHD) and to evaluate the efficacy of methylphenidate (OROS-MPH) and atomoxetine medications. Methods: To assess pharmacotherapy efficacy, the visual version of ATA was administered to 42 children with ADHD. Results were assessed using discriminant analysis, ANOVA for indices of ATA before and after medication treatment, and correlation analysis between the improvement of indices of ATA and clinical symptoms during medication treatment. Results: Discriminant analysis showed that 69.0% of ADHD children were assigned correctly. The T score of commission errors increased as the trial progressed on the medication-off condition. T scores of commission errors and standard deviation of response times on medication-on condition were low compared to the medication-off condition. A few significant correlations were found between the improvements of indices of ATA and ADHD-Rating Scale (RS) during treatment. Conclusion: The performance of the visual version of ATA on medication-off condition reflected the features of ADHD. Furthermore, the medication treatment effects were confirmed sufficiently. In addition, results suggest that indices of ATA reflected aspects of ADHD symptoms that are difficult to elucidate for ADHD-RS. For assessing symptoms and effects of medical treatment in children with ADHD, ATA might be a useful assessment tool.

Abstract

Objective: This study was conducted to validate the Advanced Test of Attention (ATA) of the visual attention version of Japanese children with attention deficit/hyperactivity disorder (ADHD) and to evaluate the efficacy of methylphenidate (OROS-MPH) and atomoxetine medications. Methods: To assess pharmacotherapy efficacy, the visual version of ATA was administered to 42 children with ADHD. Results were assessed using discriminant analysis, ANOVA for indices of ATA before and after medication treatment, and correlation analysis between the improvement of indices of ATA and clinical symptoms during medication treatment. Results: Discriminant analysis showed that 69.0% of ADHD children were assigned correctly. The T score of commission errors increased as the trial progressed on the medication-off condition. T scores of commission errors and standard deviation of response times on medication-on condition were low compared to the medication-off condition. A few significant correlations were found between the improvements of indices of ATA and ADHD-Rating Scale (RS) during treatment. Conclusion: The performance of the visual version of ATA on medication-off condition reflected the features of ADHD. Furthermore, the medication treatment effects were confirmed sufficiently. In addition, results suggest that indices of ATA reflected aspects of ADHD symptoms that are difficult to elucidate for ADHD-RS. For assessing symptoms and effects of medical treatment in children with ADHD, ATA might be a useful assessment tool.

참고문헌 (41)

  1. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders: DSM-5", American Psychiatric Association, ~ (2013)
  2. Rubia K, ""Cool" inferior frontostriatal dysfunction in attention-deficit", hyperactivity disorder versus "hot" ventromedial orbitofrontal-limbic dysfunction in conduct disorder:a review, 2011, pp.69, e69~e87
  3. Arnsten AF, "Neurobiology of executive functions:catecholamine influences on prefrontal cortical functions", Biol Psychiatry, 57, pp.1377~1384 (2005)
  4. Koechlin E, "An information theoretical approach to prefrontal executive function", Trends Cogn Sci, 11, pp.229~235 (2007)
  5. Arnsten AF, "Stimulants: Therapeutic actions in ADHD", Neuropsychopharmacology, 31, pp.2376~2383 (2006)
  6. Bidwell LC, "Cognitive enhancers for the treatment of ADHD", Pharmacol Biochem Behav, 99, pp.262~274 (2011)
  7. Rubia K, "Effects of stimulants on brain function in attentiondeficit", hyperactivity disorder: a systematic review and meta-analysis, 2014, pp.76, 616~628
  8. Rubia K, "Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task", Neuropharmacology, 57, pp.640~652 (2009)
  9. Schweren LJ, "MR imaging of the effects of methylphenidate on brain structure and function in attention-deficit", hyperactivity disorder, 2013, pp.23, 1151~1164
  10. Wehmeier PM, "Morning and evening behavior in children and adolescents treated with atomoxetine once daily for attentiondeficit", hyperactivity disorder (ADHD): findings from two 24-week, open-label studies, 2009, pp.3, 5~
  11. Riccio CA, "The continuous performance test: a window on the neural substrates for attention?", Arch Clin Neuropsychol, 17, pp.235~272 (2002)
  12. Klee SH, "The computerized continuous performance task: a new measure of inattention", J Abnorm Child Psychol, 11, pp.487~495 (1983)
  13. Shin MS, "A study of neuropsychological deficit in children with obsessivecompulsive disorder", Eur Psychiatry, 23, pp.512~520 (2008)
  14. 이승혜, "Variability of Response Time as a Predictor of Methylphenidate Treatment Response in Korean Children with Attention Deficit Hyperactivity Disorder", Yonsei Medical Journal, 50(5), pp.650~655 (2009), 연세대학교의과대학
  15. 박민현, "Differences in Performance of ADHD Children on a Visual and Auditory Continuous Performance Test according to IQ", PSYCHIATRY INVESTIGATION, 8(3), pp.227~233 (2011), 대한신경정신의학회
  16. Wang LJ, "Clinical symptoms and performance on the Continuous Performance Test in children with attention deficit hyperactivity disorder between subtypes: a natural follow-up study for 6 months", BMC Psychiatry, 11, pp.65~ (2011)
  17. Huang-Pollock CL, "Evaluating vigilance deficits in ADHD: a meta-analysis of CPT performance", J Abnorm Psychol, 121, pp.360~371 (2012)
  18. Tamm L, "Reaction time variability in ADHD: a review", Neurotherapeutics, 9, pp.500~508 (2012)
  19. DuPaul GJ, "ADHD Rating Scale - IV: Checklists, norms, and clinical interpretation" (1998), Guilford Press
  20. SPSS, "IBM SPSS statistics base 22", SPSS Inc, ~ (2013)
  21. Jung RE, "Myths of neuropsychology: intelligence, neurometabolism, and cognitive ability", Clin Neuropsychol, 14, pp.535~545 (2000)
  22. Leeson VC, "The relationship between IQ, memory, executive function, and processing speed in recent-onset psychosis: 1-year stability and clinical outcome", Schizophr Bull, 36, pp.400~409 (2010)
  23. Friedman NP, "Not all executive functions are related to intelligence", Psychol Sci, 17, pp.172~179 (2006)
  24. Naglieri JA, "Relationships between the WISC-III and the Cognitive Assessment System with Conners' rating scales and continuous performance tests", Arch Clin Neuropsychol, 20, pp.385~401 (2005)
  25. Corbett BA, "Autism and attention deficit hyperactivity disorder: assessing attention and response control with the integrated visual and auditory continuous performance test", Child Neuropsychol, 12, pp.335~348 (2006)
  26. Perugini EM, "The predictive power of combined neuropsychological measures for attention-deficit", hyperactivity disorder in children, 2000, pp.6, 101~114
  27. Rapport MD, "Do programs designed to train working memory, other executive functions, and attention benefit children with ADHD? A meta-analytic review of cognitive, academic, and behavioral outcomes", Clin Psychol Rev, 33, pp.1237~1252 (2013)
  28. Geurts HM, "ADHD subtypes: do they differ in their executive functioning profile?", Arch Clin Neuropsychol, 20, pp.457~477 (2005)
  29. Solanto MV, "Neurocognitive functioning in AD", HD, predominantly inattentive and combined subtypes, 2007, pp.35, 729~744
  30. Gómez-Guerrero L, "Response-time variability is related to parent ratings of inattention, hyperactivity, and executive function", J Atten Disord, 15, pp.572~582 (2011)
  31. Buzy WM, "Intra-individual variability among children with ADHD on a working memory task: an ex-Gaussian approach", Child Neuropsychol, 15, pp.441~459 (2009)
  32. Nydén A, "Adults with autism spectrum disorders and ADHD neuropsychological aspects", Res Dev Disabil, 31, pp.1659~1668 (2010)
  33. A. J. Lundervold, "Attention Deficits in Children With Combined Autism and ADHD: A CPT Study", Journal of Attention Disorders, 20(7), pp.599~609 (2016), SAGE Publications[DOI]
  34. McGee RA, "Does the Conners'Continuous Performance Test aid in ADHD diagnosis?", J Abnorm Child Psychol, 28, pp.415~424 (2000)
  35. Epstein JN, "Effects of stimulant medication, incentives, and event rate on reaction time variability in children with ADHD", Neuropsychopharmacology, 36, pp.1060~1072 (2011)
  36. Lee SI, "Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit", hyperactivity disorder, 2007, pp.31, 210~216
  37. Solanto MV, "Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration", Behav Brain Res, 94, pp.127~152 (1998)
  38. Johnson KA, "Dissociation in response to methylphenidate on response variability in a group of medication naïve children with ADHD", Neuropsychologia, 46, pp.1532~1541 (2008)
  39. Barkley RA, "Effects of two doses of methylphenidate on simulator driving performance in adults with attention deficit hyperactivity disorder", J Safety Res, 36, pp.121~131 (2005)
  40. Kratz O, "Differential effects of methylphenidate and atomoxetine on attentional processes in children with ADHD: an event-related potential study using the Attention Network Test", Prog Neuropsychopharmacol Biol Psychiatry, 37, pp.81~89 (2012)
  41. Yildiz O, "Atomoxetine and methylphenidate treatment in children with ADHD: the efficacy, tolerability and effects on executive functions", Child Psychiatry Hum Dev, 42, pp.257~269 (2011)

관련 논문AI추천

Effects of Methylphenidate and Atomoxetine Treatment on Improvement of Motor Coordination in Children With Attention-Deficit/Hyperactivity DisorderEunji Jung, Hyo-Won Kim, Ju Yeon Kim, Kee Jeong Park, Taeyeop Lee, Yoo-Sook Joung대한신경정신의학회 · PSYCHIATRY INVESTIGATION2025 · 제22권 제1호Multidimensional Comparison of Methylphenidate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children, a 12-Week, Open-Label, Head-to-Head Clinical TrialLin Chen, Wenran Du대한신경정신의학회 · PSYCHIATRY INVESTIGATION2025 · 제22권 제2호Differences in the Clinical Characteristics of Remission and Non-Remission Groups with Once-Daily OROS-Methylphenidate Treatment of Attention-Deficit/Hyperactivity Disorder육기환, 윤형준, 이상혁, 최태규, 홍나래, 홍현주대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2008 · 제6권 제1호Multicenter, Open-Label Study to Evaluate the Effects of Methylphenidate-OROS(Concerta) on Cognitive Functions in Children with Attention Deficit Hyperactivity Disorder서완석, 송창진, 이종훈, 정성훈, 정운선, Chulho Jung, Sangyong Choi대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2007 · 제5권 제1호Comparison between Atomoxetine and OROS Methylphenidate as an Adjunctive to SSRIs in Attention-deficit/Hyperactivity Disorder Adults with Comorbid Partially Responsive Major Depressive Disorder: A Head-to-head, 12-week, Randomized, Rater-blinded Clinical Trial김지선, 박원명, 심세훈, Heejung Yoon, Hyung Mo Sung, In Soo Heo, Jonghun Lee, Young Sup Woo대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2022 · 제20권 제1호Combined Medication with Stimulants and Non-stimulants for Attention-deficit/hyperactivity Disorder반건호, Kyunghoon Seo대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2021 · 제19권 제4호

이 간행물의 다른 논문 (15건)